American Assets Inc. Raises Holdings in Align Technology, Inc. $ALGN

American Assets Inc. lifted its holdings in Align Technology, Inc. (NASDAQ:ALGN) by 66.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,000 shares of the medical equipment provider’s stock after acquiring an additional 2,000 shares during the period. Align Technology makes up approximately 0.3% of American Assets Inc.’s portfolio, making the stock its 10th biggest position. American Assets Inc.’s holdings in Align Technology were worth $905,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Cromwell Holdings LLC lifted its stake in Align Technology by 2,900.0% in the second quarter. Cromwell Holdings LLC now owns 180 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 174 shares during the period. SVB Wealth LLC acquired a new position in shares of Align Technology during the 1st quarter valued at $36,000. Farther Finance Advisors LLC boosted its stake in Align Technology by 42.2% during the second quarter. Farther Finance Advisors LLC now owns 310 shares of the medical equipment provider’s stock worth $59,000 after acquiring an additional 92 shares in the last quarter. Mather Group LLC. grew its holdings in Align Technology by 375.0% in the first quarter. Mather Group LLC. now owns 437 shares of the medical equipment provider’s stock worth $69,000 after purchasing an additional 345 shares during the period. Finally, Assetmark Inc. increased its stake in Align Technology by 327.6% in the second quarter. Assetmark Inc. now owns 449 shares of the medical equipment provider’s stock valued at $85,000 after purchasing an additional 344 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently commented on the company. Morgan Stanley raised their target price on Align Technology from $142.00 to $154.00 and gave the company an “equal weight” rating in a research note on Thursday. Piper Sandler restated an “overweight” rating and set a $200.00 price objective (up previously from $190.00) on shares of Align Technology in a report on Thursday. Wells Fargo & Company decreased their target price on shares of Align Technology from $199.00 to $181.00 and set an “overweight” rating for the company in a research report on Thursday. Weiss Ratings cut shares of Align Technology from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Wednesday, October 8th. Finally, Leerink Partners increased their price objective on Align Technology from $172.00 to $189.00 in a research note on Thursday. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $175.45.

Align Technology Trading Down 0.4%

Align Technology stock opened at $137.88 on Monday. The business’s 50 day simple moving average is $133.23 and its 200 day simple moving average is $161.75. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $246.19. The company has a market cap of $9.99 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 1.49 and a beta of 1.70.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping the consensus estimate of $2.38 by $0.23. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The company had revenue of $995.69 million during the quarter, compared to analyst estimates of $980.75 million. During the same quarter last year, the firm posted $2.35 EPS. The firm’s revenue for the quarter was up 1.8% on a year-over-year basis. Align Technology has set its Q4 2025 guidance at EPS. As a group, equities research analysts forecast that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.

Align Technology declared that its board has authorized a share buyback plan on Tuesday, August 5th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s leadership believes its shares are undervalued.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.